Currently: BPC-157 is not FDA-approved There are no standardized treatment guidelines Long-term human safety data is lacking Large randomized clinical trials have not been completed Optimal dosing protocols have not been established Because most published research comes from animal studies, scientists cannot yet determine whether the same effects occur in humans
Thiol-reactive reagents such as N -ethylmaleimide, iodoacetic/iodoacetamide derivatives and nitric oxide donors can inactivate TST by modifying the catalytic cysteine via S -alkylation or S -nitrosylation, but they are not specific to this enzyme (Wang and Volini, 1968
Many patients notice: Weight loss may begin during this stage, although the amount varies considerably from person to person
"It's really a long-term, one could say lifelong, condition that requires lifelong management." Some people try to take the drug less often than the regular weekly injection to save money, Bedrosian said, with mixed results
These findings support the hypothesis that weight loss is largely exposure-driven and may be comparable across agents at specific dose levels